Terms of Use

This page is informational. It is not an offer to sell, or a solicitation of an offer to buy, any security. Any offer is made only to accredited investors through the current confidential offering documents of InjuryPro Management Fund X LLC. Those documents control in all respects and supersede anything stated here.

This questionnaire is intended for accredited investors located in the United States. The answers you give are self-reported. Neither your answers nor the SMS code that confirms your phone number verifies your legal accreditation status; the issuer performs that verification separately before any investment.

• It records your request so investor relations can contact you. It does not create any commitment by you or by us.
• It does not deliver offering documents. The issuer's investor materials area is password-gated, and access is granted only after review.
• It does not guarantee a response within any particular time. We do not publish a callback window.

You agree that the information you provide is accurate and that you are submitting it on your own behalf. We may decline to proceed with any request.

By ticking the consent box you agree that InjuryPro Capital may contact you by phone call, SMS and email about this offering. Message and data rates may apply. Reply STOP to opt out of SMS.

This page is for informational purposes only and is not an offer to sell or a solicitation of an offer to buy any security. Any offer is made only to accredited investors through the current confidential offering documents of InjuryPro Management Fund X LLC, which control in all respects and supersede anything stated here. The 15% figure is a target annual preferred return, not a guarantee, projection or assurance of results. Investing in private funds involves substantial risk, including illiquidity and the possible loss of your entire investment. Medical receivables are subject to collection and timing uncertainty; underwriting, servicing and collections materially affect outcomes. Quarterly distributions are subject to available cash and the offering terms. The fund term is 60 months with a 12-month initial lockup; redemptions afterwards are conditional and subject to limits and available cash. Self-reported answers and SMS phone verification do not verify legal accreditation status. Past performance is not indicative of future results. Nothing here is legal, tax, accounting or investment advice, and nothing here is an assurance of approval by any regulator, platform or advertising network.

InjuryPro Capital — investorrelations@injuryprocapital.com — 1-888-290-3369